New York private equity firm Warburg Pincus has invested $92 million in Laurus Labs Private Ltd., an Indian pharmaceutical company.

Laurus, headquartered in Visakhapatnam, India, develops and manufactures active pharmaceutical ingredients that are used for anti-retroviral, oncology, cardiovascular and anti-diabetic drugs.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.